Insider Transactions in Q2 2023 at Cti Biopharma Corp (CTIC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Bvf Partners L P Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,569,286
-100.0%
|
$14,123,574
$9.1 P/Share
|
|
Jun 26
2023
|
Bvf Partners L P Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,286,874
-100.0%
|
$65,581,866
$9.1 P/Share
|
|
Jun 26
2023
|
James K Fong EVP & Chief Commercial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,565
-100.0%
|
$32,085
$9.1 P/Share
|
|
Jun 26
2023
|
Adam R Craig President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
31,470
-100.0%
|
$283,230
$9.1 P/Share
|
|
Jun 26
2023
|
David Kirske EVP, Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,547
-100.0%
|
$157,923
$9.1 P/Share
|
|
Jun 26
2023
|
Reed Vaughn Tuckson Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
48,639
-100.0%
|
$437,751
$9.1 P/Share
|
|
Jun 26
2023
|
Matthew D Perry Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
43,139
-100.0%
|
$388,251
$9.1 P/Share
|